1.The Role of Hepatitis Virus and Alcohol in Chronic Liver Disease.
The Korean Journal of Hepatology 1999;5(2):83-88
No abstract availalbe
Hepatitis Viruses*
;
Hepatitis*
;
Liver Diseases*
;
Liver*
2.Insulin Resistance in Chronic Hepatitis C: Association with Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis.
Moon Young KIM ; Soon Koo BAIK
The Korean Journal of Gastroenterology 2008;51(4):269-270
No abstract available.
3.Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease.
Moon Young KIM ; Soon Koo BAIK
The Korean Journal of Hepatology 2008;14(1):1-3
No abstract available.
Carotid Arteries/pathology/ultrasonography
;
Carotid Artery Diseases/diagnosis/*etiology
;
Diabetes Mellitus, Type 2/complications/diagnosis
;
Fatty Liver/*complications/diagnosis/ultrasonography
;
Humans
;
Metabolic Syndrome X/complications/diagnosis
;
Obesity/complications/diagnosis
;
Risk Factors
4.Disseminated intravascular coagulation(DIC) associated with gastric adenocarcinoma.
Soon Koo BAIK ; Heon Soo KIM ; Jong In LEE ; Woo Ick JANG ; Young Hak SHIM
Journal of the Korean Cancer Association 1992;24(3):456-462
No abstract available.
Adenocarcinoma*
5.Role of Doppler Ultrasonography in Portal Hypertension.
The Korean Journal of Gastroenterology 2006;48(3):215-217
No abstract availble.
Blood Flow Velocity
;
Humans
;
Hypertension, Portal/*ultrasonography
;
Liver Cirrhosis/pathology
;
Portal Vein/ultrasonography
;
*Ultrasonography, Doppler
6.Assessment for Risk of Bias in Systematic Reviews and Meta-Analyses in the Field of Hepatology.
Gaeun KIM ; Youn Zoo CHO ; Soon Koo BAIK
Gut and Liver 2015;9(6):701-706
A systematic review (SR) provides the best and most objective analysis of the existing evidence in a particular field. SRs and derived conclusions are essential for evidence-based strategies in medicine and evidence-based guidelines in clinical practice. The popularity of SRs has also increased markedly in the field of hepatology. However, although SRs are considered to provide a higher level of evidence with greater confidence than original articles, there have been no reports on the quality of SRs and meta-analyses (MAs) in the field of hepatology. Therefore, we performed a quality assessment of 225 SRs and MAs that were recently published in the field of hepatology (January 2011 to September 2014) using A MeaSurement Tool to Assess systematic Reviews (AMSTAR). Using AMSTAR, we revealed both a shortage of assessments of the scientific quality of individual studies and a publication bias in many SRs and MAs. This review addresses the concern that SRs and MAs need to be conducted in a stricter and more objective manner to minimize bias and random errors. Thus, SRs and MAs should be supported by a multi-disciplinary approach that includes clinical experts, methodologists, and statisticians.
*Gastroenterology
;
Humans
;
*Meta-Analysis as Topic
;
*Publication Bias
;
*Review Literature as Topic
7.Pharmacological Therapy of Portal Hypertension: Focused on Korean Data.
The Korean Journal of Gastroenterology 2005;45(6):381-386
Portal hypertension as a consequence of liver cirrhosis is responsible for serious complications such as variceal bleeding, ascites and hepatic encephalopathy. Successful pharmacological treatment of portal hypertension can prevent the risk of the variceal bleeding, and contribute to reduce the morbidity and mortality in patients with liver cirrhosis. To identify the effect of drugs on portal hypertension, portal pressure was evaluated accurately before and after the drug administration. The hepatic venous pressure gradient has been accepted as the gold-standard method for assessing the severity of portal hypertension and the response to drug treatment. The mean hepatic venous pressure gradient was 15.1+/-5.4 mmHg in Korean cirrhotic patients who had experienced variceal bleeding. Non-selective beta blockers are the treatment of choice for primary and secondary prevention of variceal bleeding. The dose of propranolol should be subsequently adjusted until the resting heart rate had been reduced by 25% or less than 55 beats per minute. It has been reported that the optimal dose of propranolol is variable due to racial differences in cardiovascular receptor sensitivity. In Korean patients with portal hypertension and liver cirrhosis, the mean required dose of propranolol to reach target heart rate was 165 mg (range; 80-280 mg). This review covers mainly the results of the pharmacological therapy of portal hypertension in Korean cirrhotic patients.
Adrenergic beta-Antagonists/administration & dosage
;
Hepatic Veins
;
Humans
;
Hypertension, Portal/diagnosis/*drug therapy/physiopathology
;
Korea
;
Liver Cirrhosis/complications/physiopathology
;
Propranolol/administration & dosage
;
Venous Pressure/drug effects
8.Overview and recent trends of systematic reviews and meta-analyses in hepatology.
Clinical and Molecular Hepatology 2014;20(2):137-150
A systematic review (SR) is a research methodology that involves a comprehensive search for and analysis of relevant studies on a specific topic. A strict and objective research process is conducted that comprises a systematic and comprehensive literature search in accordance with predetermined inclusion/exclusion criteria, and an assessment of the risk of bias of the selected literature. SRs require a multidisciplinary approach that necessitates cooperation with clinical experts, methodologists, other experts, and statisticians. A meta-analysis (MA) is a statistical method of quantitatively synthesizing data, where possible, from the primary literature selected for the SR. Review articles differ from SRs in that they lack a systematic methodology such as a literature search, selection of studies according to strict criteria, assessment of risk bias, and synthesis of the study results. The importance of evidence-based medicine (EBM) in the decision-making for public policy has recently been increasing thanks to the realization that it should be based on scientific research data. SRs and MAs are essential for EBM strategy and evidence-based clinical practice guidelines. This review addresses the current trends in SRs and MAs in the field of hepatology via a search of recently published articles in the Cochrane Library and Ovid-MEDLINE.
Databases, Factual
;
Fatty Liver/pathology
;
Gastroenterology/*trends
;
Hepatitis B/pathology
;
Hepatitis C/pathology
;
Humans
;
Liver Cirrhosis/pathology
;
Liver Neoplasms/pathology
;
Peer Review, Research/*trends
9.Assessment and Current Treatment of Portal Hypertension.
The Korean Journal of Hepatology 2005;11(3):211-217
No abstract available.
Humans
;
*Hypertension, Portal/diagnosis/therapy
10.Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis.
Gaeun KIM ; Kwang Yong SHIM ; Soon Koo BAIK
Gut and Liver 2017;11(1):93-101
BACKGROUND/AIMS: We identified reports in the literature regarding the diagnostic accuracy of hepatic vein arrival time (HVAT) measured by contrast-enhanced ultrasonography (CEUS) to assess hepatic fibrosis in cirrhosis. METHODS: The Ovid MEDLINE, Embase, and Cochrane databases were searched for all studies published up to 23 July 2015 that evaluated liver status using CEUS and liver biopsy (LB). The QUADAS-II (quality assessment of diagnostic accuracy studies-II) was applied to assess the internal validity of the diagnostic studies. Selected studies were subjected to a meta-analysis with MetaDisc 1.4 and RevMan 5.3. RESULTS: A total of 12 studies including 844 patients with chronic liver disease met our inclusion criteria. The overall summary sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of the HVAT measured by CEUS for the detection of cirrhosis compared to LB were 0.83 (95% confidence interval [CI], 0.77 to 0.89), 0.75 (95% CI, 0.69 to 0.79), 3.45 (95% CI, 1.60 to 7.43), and 0.28 (95% CI, 0.10 to 0.74), respectively. The summary diagnostic odds ratio (random effects model) was 15.23 (95% CI, 3.07 to 75.47), the summary receiver operator characteristics area under the curve was 0.74 (standard error [SE]=0.14), and the index Q was 0.69 (SE=0.11). CONCLUSIONS: Based on a systematic review, the measurement of HVAT by CEUS exhibited an increased accuracy and correlation for the detection of cirrhosis.
Biopsy
;
Fibrosis*
;
Hepatic Veins*
;
Humans
;
Liver
;
Liver Diseases
;
Odds Ratio
;
Sensitivity and Specificity
;
Ultrasonography*